Cataract
Conditions
Brief summary
Evaluate if the incidence of sub clinical CME can be significantly reduced by use of peri-operative Acular LS plus Pred Forte when compared with Pred Forte alone in normal cataract patients.
Interventions
DRUGKetorolac, Prednisolone Acetate
Sponsors
Innovative Medical
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* · Male or female \> 18 years of age scheduled to undergo cataract surgery with surgeon expectation of 20/20 BCVA postoperatively * Must be in good general health. Patients with systemic diseases will be enrolled only if there are no ocular manifestations of their disease (ie diabetics with normal retinal exams) * Ability to provide informed consent and likely to complete all study visits
Exclusion criteria
* · Known contraindication to any study medication or any of their components * Uncontrolled systemic disease * Required use of ocular medications other than the study medications during the study * Abnormal pre-operative OCTs if obtainable * Diabetic patients with a history of macular edema or diabetic retinopathy * AMD patients with less than a 20/20 surgical outcome expectation, epi-retinal membranes, retinal vein occlusion, or any pre-existing macular disease
Countries
United States
Outcome results
None listed